Referable Macular Hemorrhage-A Clinically Meaningful Screening Target in Newborn Infants. Position Statement of the Association of Pediatric Retina Surgeons

Wood E. H., Capone A., Drenser K. A., Berrocal A., Hubbard G. B., Callaway N. F., ...Daha Fazla

OPHTHALMIC SURGERY LASERS & IMAGING RETINA, cilt.53, sa.1, ss.3-6, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 53 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.3928/23258160-20211214-01
  • Dergi Adı: OPHTHALMIC SURGERY LASERS & IMAGING RETINA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Sayfa Sayıları: ss.3-6
  • Gazi Üniversitesi Adresli: Hayır

Özet

Universal newborn eye screening facilitates early diagnosis of ocular abnormalities and mitigates vision loss. "Referral warranted" eye disease is present at birth in about 5.5% of term infants, with "macular hemorrhage impinging on the fovea" representing about 50% of referral warranted disease. The Association of Pediatric Retina Surgeons held a symposium on February 9, 2021 that culminated in a position statement on "referable macular hemorrhage" (RMH) in newborn infants. RMH is meaningful in that in can cause amblyopia through deprivation, can be readily captured with wide-angle photography in a safe and efficient manner, and may lead to early intervention with mitigation of vision loss.